Skip to content

A study on development of SPURLESK

A study in the development of Spine-Padding Under Robe Lessening Spurs by Kyphosis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1080225008
Enrollment
35
Registered
2020-01-08
Start date
2020-01-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients after PVP for vertebral fractures

Interventions

investigational material(s) Generic name etc : A casual underwear covering the protruded spinous processes INN of investigational material : Therapeutic category code : Dosage and Administration for

Sponsors

National Center for Global Health and Medicine Yumi Matsushita
Lead Sponsor
National Hospital Organization Kyushu Medical Center Tomoyuki Noguchi
Collaborator
National Center for Global Health and Medicine Yoshitaka Shida
Collaborator
National Institute of Public Health Tetsuji Yokoyama
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult in- or out-patients after PVP for vertebral fractures at the collaboration institutions between the date of Institutional Review Board approval and March 31, 2021 who have ability or a nursing care enough that they can try on SPURLESK for a 5-day and answer questionnaires, and hand in the questionnares and SPURLESK at the timing of regular post-operative follow-up.

Exclusion criteria

Exclusion criteria: Patients with cognitive decline who have difficulty responding to the questionnaires for wearing SPURLESK. Patients who are judged to be difficult to wear properly despite the fact that the principal investigator, conducting investigator, or co-investigator explain the precautions for wearing SPURLEST with the precaution document are excluded.

Design outcomes

Primary

MeasureTime frame
safety confirmatory We describe the mean, standard deviation, and histogram of the results from the questionnaire.

Secondary

MeasureTime frame
safety confirmatory We describe the mean, standard deviation, and histogram of the patients' anthropometric data.

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026